Rentschler Biopharma responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany
CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV
- CureVac further strengthens its global manufacturing network
- Rentschler Biopharma responsible for manufacturing, downstream processing and formulation of CureVac's CVnCoV in Laupheim, Germany
- Process optimization currently under way to maximize drug product output
CureVac N.V. (Nasdaq: CVAC), a b…